Delivery Order SPE2DB22D2006-SPE2DB25FW3RP
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count) on September 8, 2025, with a ceiling value of $3,447.42 and an ultimate completion date of September 9, 2025. This firm fixed-price delivery order represents a non-set-aside competitive procurement and is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $1,344.93 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count package) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical...
- The Defense Logistics Agency awarded a delivery order valued at $7,914.33 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count units) under a firm fixed-price contract. The award, executed on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this transaction and is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $12,842.64 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Kerendia 10 mg tablets (30-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, and performance will be completed by August 14, 2025, at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,212.34 to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (30-count units) under a firm fixed price contract type. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive delivery order fulfilled by the prime contractor's Conshohocken, Pennsylvania facility. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,642.05 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count packages) under a firm fixed price contract. The award was made on September 16, 2025, with an ultimate completion date of September 17, 2025, and represents a non-competitive delivery against an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Kerendia 20 mg tablets (30-count units) with a ceiling value of $27,471.06. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on June 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the company's competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Kerendia 10 mg tablets (30-count units) with a contract ceiling value of $59,930.82. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order valued at $17,656.81 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count units) under a firm fixed price contract. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $38,149.93 to supply Kerendia 10 mg tablets (30-count units) with a firm fixed price structure. This competitive award, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract does not utilize a set-aside designation and will be performed at the...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3RPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count) under a firm fixed-price contract valued at $12,323.76. The award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a non-competitive delivery order placed against the contractor's existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's prime indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The Kerendia supply fulfills ongoing pharmaceutical needs within the Defense Health Agency and other government healthcare systems, consistent with the contractor's extensive portfolio of competitively awarded federal medical product deliveries across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 8/18/25 |